A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ
- PMID: 23641041
- PMCID: PMC3653826
- DOI: 10.1093/jnci/djt098
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ
Comment on
-
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.J Natl Cancer Inst. 2013 May 15;105(10):701-10. doi: 10.1093/jnci/djt067. Epub 2013 May 2. J Natl Cancer Inst. 2013. PMID: 23641039 Free PMC article.
References
-
- Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443–448 - PubMed
-
- Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546–1554 - PubMed
-
- Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer. 1999;85(3):616–628 - PubMed
-
- Rashtian A, Iganej S, Amy Liu I-L A, et al. Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy.. Int J Radiation Oncology Biol Phys. 2008;72(4):1016–1020 - PubMed
-
- Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16(2):441–452 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
